St. Jude Medical seesaws on FDA warning letter

Tue, 01/15/2013 - 4:29pm
Mass Device

Wall Street investors send shares of St. Jude Medical up yesterday and down today after the company reveals a warning letter from the FDA over its Sylmar, Calif., Durata defibrillator lead plant. Wall Street Beat

A warning letter from the FDA to St. Jude Medical (NYSE:STJ) sent the St. Paul, Minn.-based medical device company's stock on a seesaw ride yesterday and today.

STJ shares closed up 1.5% yesterday at $38.85 each after St. Jude revealed the warning letter, but closed down 1.2% today at $38.39 apiece.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.